4SF-27125-69236
3 vaccinations
2 coded responses
39 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 932 / CA
- Registered
- 2021-06-13
- Relationship
- Self
- Race
- N/A
- Ethnicity
- Hispanic or Latino
Registered dependents
JL5-27382-92426
Child or adolescent in my care · Female · 2022-06-26
Timeline
-
2021-06-12
Dose 1 — Pfizer-BioNTech
-
2021-06-13
Registered in v-safe
- 2021-06-13
-
2021-06-14
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Chills, Headache · Be unable to work or attend schoolAdult check-in
-
2021-06-15
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fever · Muscle or body aches, Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
-
2021-06-16
Health check-in — days 1–6 daily, dose 1Feeling: Good · Headache · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationAdult check-in
-
2021-06-16
Report sent to call center — days 1–6 daily, dose 1Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-17
- 2021-06-18
- 2021-06-19
- 2021-06-23
- 2021-06-29
-
2021-07-03
Dose 2 — Pfizer-BioNTechCo-administered: yes
- 2021-07-03
- 2021-07-04
- 2021-07-05
- 2021-07-06
- 2021-07-07
- 2021-07-08
- 2021-07-09
- 2021-07-12
- 2021-07-17
-
2021-07-24
Survey response — day 21, dose 2MedDRA: Headache — Feeling: GoodFree text: HeadacheMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-07-31
- 2021-08-07
-
2021-08-14
Survey response — day 42, dose 2MedDRA: Headache — Feeling: FairFree text: HeadacheMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-10-02
- 2022-01-01
-
2022-01-03
Dose 3 — Pfizer-BioNTech
- 2022-01-03
-
2022-01-04
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2022-01-05
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-01-06
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Swelling · Headache, Fatigue or tirednessAdult check-in
-
2022-01-07
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Swelling · Fatigue or tirednessAdult check-in
- 2022-01-08
-
2022-01-09
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-01-10
- 2022-01-17
- 2022-01-24
- 2022-01-31
- 2022-02-07
- 2022-02-14
- 2022-04-04
- 2022-07-04
- 2023-01-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-06-12 | Pfizer-BioNTech | |
| 2 | 2021-07-03 | Pfizer-BioNTech | Yes |
| 3 | 2022-01-03 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-06-16 | Unsuccessful |
Free text
Release 9 — day 21, dose 2
Symptoms: Headache
Release 9 — day 42, dose 2
Symptoms: Headache
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release